MedPath

Sodium bicarbonate

Generic Name
Sodium bicarbonate
Brand Names
Alka-seltzer, Alka-seltzer Fruit Chews, Alka-seltzer Heartburn Relief, Bi-peglyte, Bibag, Bicart, Bss Ophthalmic Solution, Ceo-two, Colyte, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hema Bp-38, Hemacart, Konvomep, Nulytely, Peglyte, Phoxillum, Physioneal 40, Prismasol, Zegerid, Zegerid Reformulated Aug 2006, Zegerid With Magnesium Hydroxide
Drug Type
Small Molecule
Chemical Formula
CHNaO3
CAS Number
144-55-8
Unique Ingredient Identifier
8MDF5V39QO
Background

Sodium bicarbonate is a white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.

Indication

Sodium bicarbonate is used for the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturateprotein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments.

Associated Conditions
Barbiturate intoxication, Breast Cancer, Constipation, Dental Decay, Duodenal Ulcer, Dyspepsia, Gastro-esophageal Reflux Disease (GERD), Gingival Bleeding, Heartburn, Helicobacter Infections, Hyperkalemia, Ischaemia, Metabolic Acidosis, Myocardial Infarction, Plaque, Dental, Pruritis of the skin, Skin Irritation, Upper GI Bleeding, Upset stomach, Zollinger-Ellison Syndrome, Abdominal bloating, Benign, active Gastric Ulcer, Methyl alcohol poisoning, Prophylaxis of Contrast-induced nephropathy, Salicylate poisoning, Severe Diarrhea, Swelling of the gums
Associated Therapies
Bowel preparation therapy

Effect of Sodium Bicarbonate Buffered Lidocaine on the Success of IAN Block of Teeth With Irreversible Pulpitis

Phase 3
Completed
Conditions
Local Anesthesia
Interventions
First Posted Date
2014-08-27
Last Posted Date
2016-08-31
Lead Sponsor
Masoud Saatchi
Target Recruit Count
80
Registration Number
NCT02226913

Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery

Phase 2
Terminated
Conditions
Acute Kidney Injury
Congenital Heart Disease
Interventions
First Posted Date
2014-01-27
Last Posted Date
2022-11-02
Lead Sponsor
Northwell Health
Target Recruit Count
51
Registration Number
NCT02046135
Locations
🇺🇸

Cohen Children's Medical Center of New York, New Hyde Park, New York, United States

Metabolic Acidosis and Vascular Function in Patients With Chronic Kidney Disease

Not Applicable
Completed
Conditions
Metabolic Acidosis
Chronic Kidney Disease
Interventions
First Posted Date
2014-01-09
Last Posted Date
2020-09-22
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
20
Registration Number
NCT02031770
Locations
🇺🇸

University of Colorado Denver, Aurora, Colorado, United States

The Effect of Sodium Bicarbonate on Postoperative Renal Function in Infective Endocarditis Patients Undergoing Open Heart Surgery

Phase 4
Completed
Conditions
Acute Kidney Injury
Interventions
First Posted Date
2013-08-09
Last Posted Date
2018-07-17
Lead Sponsor
Yonsei University
Target Recruit Count
70
Registration Number
NCT01920126
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease

Phase 1
Terminated
Conditions
Metabolic Acidosis
Chronic Kidney Disease
Sickle Cell Anemia
Interventions
First Posted Date
2013-07-10
Last Posted Date
2019-03-20
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
7
Registration Number
NCT01894594
Locations
🇺🇸

University hospitals Case Medical Center, Cleveland, Ohio, United States

Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain

Phase 1
Terminated
Conditions
Pain
Unresectable Malignant Neoplasm
Lymphoma
Cancer
Tumor
Malignant Solid Tumor
Neoplasm Metastasis
Hematologic Malignancy
Multiple Myeloma
Interventions
First Posted Date
2013-05-03
Last Posted Date
2015-06-04
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
9
Registration Number
NCT01846429
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Effect of Sodium Bicarbonate on Prevention of Acute Kidney Injury in High Risk Patients Undergoing Off-pump Coronary Artery Bypass (OPCAB)

Not Applicable
Completed
Conditions
Acute Kidney Injury
Interventions
Drug: normal saline
First Posted Date
2013-04-25
Last Posted Date
2017-10-27
Lead Sponsor
Yonsei University
Target Recruit Count
162
Registration Number
NCT01840241
Locations
🇰🇷

Department of anesthesiology and pain medicine, Seoul, Korea, Republic of

A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions

Phase 1
Completed
Conditions
Acid Reflux
Gastro Oesophageal Reflux Disease
Interventions
First Posted Date
2012-10-19
Last Posted Date
2012-10-19
Lead Sponsor
Norgine
Target Recruit Count
20
Registration Number
NCT01710995
Locations
🇬🇧

Bio-Kinetic Europe Limited, 14 Great Victoria Street, Belfast BT2 7BA, Belfast, United Kingdom

Comparison of Pain of Conventional to Buffered Local Anesthesia During Injection in Pediatric Dental Patients

Phase 4
Completed
Conditions
Pain
Interventions
First Posted Date
2012-06-19
Last Posted Date
2014-03-17
Lead Sponsor
University of California, San Francisco
Target Recruit Count
20
Registration Number
NCT01622296
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.

Not Applicable
Completed
Conditions
Diabetes Mellitus
Chronic Renal Insufficiency
Interventions
First Posted Date
2012-04-10
Last Posted Date
2019-08-28
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
74
Registration Number
NCT01574157
Locations
🇺🇸

VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath